Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.

MLA

Miin Roh, et al. “Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF-α), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma.” PLoS ONE, vol. 7, no. 7, Jan. 2012, p. e40065. EBSCOhost, https://doi.org/10.1371/journal.pone.0040065.

APA

Miin Roh, Yan Zhang, Yusuke Murakami, Aristomenis Thanos, Sung Chul Lee, Demetrios G Vavvas, Larry I Benowitz, & Joan W Miller. (2012). Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS ONE, 7(7), e40065. https://doi.org/10.1371/journal.pone.0040065

Chicago

Miin Roh, Yan Zhang, Yusuke Murakami, Aristomenis Thanos, Sung Chul Lee, Demetrios G Vavvas, Larry I Benowitz, and Joan W Miller. 2012. “Etanercept, a Widely Used Inhibitor of Tumor Necrosis Factor-α (TNF-α), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma.” PLoS ONE 7 (7): e40065. doi:10.1371/journal.pone.0040065.